Total Payments
$178,263
2024 Payments
$75,356
Companies
9
Transactions
208
Medicare Patients
227
Medicare Billing
$29,775
Payment Breakdown by Category
Other$137,313 (77.0%)
Travel$20,525 (11.5%)
Consulting$13,742 (7.7%)
Food & Beverage$6,683 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $137,313 | 62 | 77.0% |
| Travel and Lodging | $20,525 | 48 | 11.5% |
| Consulting Fee | $13,742 | 5 | 7.7% |
| Food and Beverage | $6,683 | 93 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $71,748 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $53,784 | 64 | $0 (2024) |
| GlaxoSmithKline, LLC. | $51,834 | 45 | $0 (2024) |
| ABBVIE INC. | $277.04 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $196.65 | 2 | $0 (2019) |
| Amgen Inc. | $171.94 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $119.93 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $99.19 | 1 | $0 (2018) |
| ARGENX US, INC. | $31.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,356 | 86 | AstraZeneca Pharmaceuticals LP ($42,307) |
| 2023 | $47,401 | 52 | Aurinia Pharma U.S., Inc. ($19,887) |
| 2022 | $32,706 | 34 | Aurinia Pharma U.S., Inc. ($25,702) |
| 2021 | $22,336 | 30 | Aurinia Pharma U.S., Inc. ($22,262) |
| 2020 | $25.13 | 1 | AbbVie Inc. ($25.13) |
| 2019 | $119.66 | 2 | SANOFI-AVENTIS U.S. LLC ($97.14) |
| 2018 | $99.19 | 1 | E.R. Squibb & Sons, L.L.C. ($99.19) |
| 2017 | $219.44 | 2 | Novartis Pharmaceuticals Corporation ($119.93) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $862.18 | General |
| 12/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $62.28 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $1,359.75 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $118.81 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $148.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $63.85 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $131.19 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $85.95 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $84.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $335.90 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $285.60 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $210.32 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $53.76 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $854.89 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $125.03 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 68 | 119 | $52,150 | $9,917 |
| 2022 | 2 | 53 | 76 | $26,400 | $4,887 |
| 2021 | 2 | 58 | 98 | $37,200 | $7,651 |
| 2020 | 2 | 48 | 82 | $36,650 | $7,320 |
Total Patients
227
Total Services
375
Medicare Billing
$29,775
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 75 | $30,000 | $5,735 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 31 | $12,400 | $2,186 | 17.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $9,750 | $1,996 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 26 | $10,400 | $1,826 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 32 | $8,800 | $1,769 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 18 | $7,200 | $1,292 | 17.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 55 | $22,000 | $4,455 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 27 | $10,800 | $2,323 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 16 | $4,400 | $872.70 | 19.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 42 | $16,800 | $3,824 | 22.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $8,250 | $1,768 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 29 | $11,600 | $1,729 | 14.9% |
About Dr. Leanna Wise, M.D
Dr. Leanna Wise, M.D is a Rheumatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1881013548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leanna Wise, M.D has received a total of $178,263 in payments from pharmaceutical and medical device companies, with $75,356 received in 2024. These payments were reported across 208 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($137,313).
As a Medicare-enrolled provider, Wise has provided services to 227 Medicare beneficiaries, totaling 375 services with total Medicare billing of $29,775. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Los Angeles, CA
- Active Since 04/09/2014
- Last Updated 11/27/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881013548
Products in Payments
- LUPKYNIS (Drug) $67,748
- SAPHNELO (Biological) $52,571
- BENLYSTA (Biological) $51,834
- RINVOQ (Biological) $209.76
- KEVZARA (Drug) $196.65
- KRYSTEXXA (Biological) $149.42
- ORENCIA (Biological) $99.19
- SKYRIZI (Biological) $26.64
- RINVOQ (Drug) $25.13
- HUMIRA (Biological) $15.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Los Angeles
Dr. Glenn Ehresmann, M.d, M.D
Rheumatology — Payments: $770,098
Rheumatology $770,098
Dr. Daniel Arkfeld, M.d, M.D
Rheumatology — Payments: $570,588
Rheumatology $570,588
Maureen Mcmahon, Md, MD
Rheumatology — Payments: $327,802
Rheumatology $327,802
Jon Giles, M.d, M.D
Rheumatology — Payments: $285,629
Rheumatology $285,629
Christina Charles-Schoeman, Md, MD
Rheumatology — Payments: $281,888
Rheumatology $281,888
Thomas Romano, M.d, M.D
Rheumatology — Payments: $230,456
Rheumatology $230,456